What Eli Lilly’s new employer platform could mean for access to weight-loss drugs
Eli Lilly wants to get its obesity drugs into the hands of more Americans and it’s betting on employers to help do so. The Indianapolis-based drugmaker launched a new program on Thursday that’s designed to offer employers more options for covering obesity drugs, thereby lowering the cost barriers to access for employees. Lilly and rival Novo Nordisk have taken various steps in recent months to slash the prices of their now-popular GLP-1 medications, and Lilly’s latest move is intended to clos...
📰 Original Source
Read full article at Fastcompany →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.